eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
5/2010
vol. 9
 
Share:
Send email
Share:
abstract:
Original paper

Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy

Agnieszka Kołacińska
,
Maria Błasińska-Morawiec
,
Izabela Dowgier-Witczak
,
Radzisław Kordek
,
Zbigniew Morawiec

Przegląd Menopauzalny 2010; 5: 300–304
Online publish date: 2010/10/27
View full text Get citation
 
Objectives : Pathological complete response (pCR) after neoadjuvant systemic treatment, used in inoperable locally advanced breast cancers or resectable tumours with the intent to reduce their size, is defined as no residual cancer in the breast and axilla reported by the pathologist.

Aim : The aim of the study is to characterize breast cancer patients who achieved pathological complete response after neoadjuvant systemic treatment.

Material and methods : 101 consecutive patients with locally advanced breast cancer, operated on after adjuvant systemic treatment, were enrolled in the study.

Results : 8.91% of patients achieved a pCR.

Conclusions : The highest rate of pCR was observed in triple negative breast cancer patients, G3, with invasive ductal carcinoma, receiving a combination of anthracycline- and taxane-based chemotherapy.
keywords:

breast cancer, pathological complete response, preoperative systemic treatment
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.